scholarly journals Massive lymphatic leakage after lung cancer surgery via median sternotomy

2019 ◽  
Vol 2019 (7) ◽  
Author(s):  
Kentaro Minegishi ◽  
Hiroyoshi Tsubochi ◽  
Kohei Hamamoto ◽  
Shunsuke Endo
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Thoracic Duct ◽  
Median Sternotomy ◽  
Lung Cancer Surgery ◽  
Posterior Mediastinum ◽  
Left Posterior ◽  
Nodal Dissection ◽  
Chylous Leakage ◽  
Middle Mediastinum

Abstract We report a case of intractable chylothorax after right upper lobectomy and nodal dissection via median sternotomy for lung cancer in a 67-year-old man. Lymphangiography (LAG) with lipiodol and sequential computed tomography showed the thoracic duct in the left posterior mediastinum and massive lymphatic leakage in the anterior and middle mediastinum. The Chylous leakage was resolved by LAG with lipiodol. Our findings suggest that variation of the thoracic duct should be evaluated by LAG when intractable chylothorax or chylomediastinum develops after anterior mediastinal surgery.

scholarly journals Three Dimensional Computed Tomography Lung Modeling is Useful in Simulation and Navigation of Lung Cancer Surgery

2013 ◽  
Vol 19 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Norihiko Ikeda ◽  
Akinobu Yoshimura ◽  
Masaru Hagiwara ◽  
Soichi Akata ◽  
Hisashi Saji
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Three Dimensional ◽  
Lung Cancer Surgery ◽  
Cancer Surgery

scholarly journals Quantitative computed tomography to predict postoperative FEV1 after lung cancer surgery

2017 ◽  
Vol 9 (8) ◽  
pp. 2413-2418 ◽  
Author(s):  
Alex Fourdrain ◽  
Florence De Dominicis ◽  
Sophie Lafitte ◽  
Jules Iquille ◽  
Flavien Prevot ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Quantitative Computed Tomography ◽  
Lung Cancer Surgery ◽  
Cancer Surgery ◽  
Postoperative Fev1

scholarly journals WS05.03 How to Perform a Proper Systematic Nodal Dissection in Lung Cancer Surgery

2019 ◽  
Vol 14 (10) ◽  
pp. S1113
Author(s):  
K. Masai ◽  
K. Kaseda ◽  
K. Asakura ◽  
T. Hishida ◽  
H. Asamura
Keyword(s):  
Lung Cancer ◽  
Lung Cancer Surgery ◽  
Cancer Surgery ◽  
Nodal Dissection ◽  
Systematic Nodal Dissection

scholarly journals The Evolving Concept of Complete Resection in Lung Cancer Surgery

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2583
Author(s):  
Ramón Rami-Porta
Keyword(s):  
Lung Cancer ◽  
International Association ◽  
Lung Cancer Surgery ◽  
Residual Tumor ◽  
Complete Resection ◽  
Resection Margins ◽  
The Status ◽  
Nodal Dissection ◽  
Definition Of ◽  
Systematic Nodal Dissection

Different definitions of complete resection were formulated to complement the residual tumor (R) descriptor proposed by the American Joint Committee on Cancer in 1977. The definitions went beyond resection margins to include the status of the visceral pleura, the most distant nodes and the nodal capsule and the performance of a complete mediastinal lymphadenectomy. In 2005, the International Association for the Study of Lung Cancer (IASLC) proposed definitions for complete, incomplete and uncertain resections for international implementation. Central to the IASLC definition of complete resection is an adequate nodal evaluation either by systematic nodal dissection or lobe-specific systematic nodal dissection, as well as the integrity of the highest mediastinal node, the nodal capsule and the resection margins. When there is evidence of cancer remaining after treatment, the resection is incomplete, and when all margins are free of tumor, but the conditions for complete resection are not fulfilled, the resection is defined as uncertain. The prognostic relevance of the definitions has been validated by four studies. The definitions can be improved in the future by considering the cells spread through air spaces, the residual tumor cells, DNA or RNA in the blood, and the determination of the adequate margins and lymphadenectomy in sublobar resections.

scholarly journals Chylothorax associated with lymphatic reflux in a thoracic duct tributary after lung cancer surgery

2021 ◽  
Author(s):  
Hironori Ishida ◽  
Ken Nakazawa ◽  
Akitoshi Yanagihara ◽  
Tetsuya Umesaki ◽  
Ryo Taguchi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Thoracic Duct ◽  
Lung Cancer Surgery ◽  
Cancer Surgery

scholarly journals Aberrant course of thoracic duct in a case of chylothorax after lung cancer surgery

2010 ◽  
Vol 24 (1) ◽  
pp. 039-043
Author(s):  
Fumihiro Ishibashi ◽  
Tomohisa Yasukawa ◽  
Hironobu Shiota ◽  
Tomoko Soh ◽  
Toshikazu Yusa
Keyword(s):  
Lung Cancer ◽  
Thoracic Duct ◽  
Lung Cancer Surgery ◽  
Cancer Surgery

scholarly journals Uniportal video-assisted thoracic surgery and perioperative pirfenidone for lung cancer and idiopathic pulmonary fibrosis: a case report

2021 ◽  
Vol 49 (9) ◽  
pp. 030006052110169
Author(s):  
Ayae Saiki ◽  
Teruaki Mizobuchi ◽  
Kaoru Nagato ◽  
Fumihiro Ishibashi ◽  
Junichi Tsuyusaki ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Primary Lung Cancer ◽  
Lung Cancer Surgery ◽  
Lower Lobe ◽  
Chest Computed Tomography ◽  
Video Assisted ◽  
Acute Exacerbations

Patients with idiopathic pulmonary fibrosis (IPF) occasionally experience acute exacerbations after surgery for lung cancer. Several recent studies have revealed a prophylactic effect of perioperative pirfenidone treatment on postoperative acute exacerbations of IPF in patients with lung cancer. A 75-year-old woman consulted with her pulmonologist because of an IPF shadow detected by follow-up chest computed tomography 2 months after surgical treatment of biliary cancer. Another 7 months later, chest computed tomography showed a 23- × 14-mm nodule located in the right lower lobe with high accumulation of fluorodeoxyglucose detected by positron emission tomography, resulting in a radiological diagnosis of primary lung cancer with IPF. We administered perioperative pirfenidone treatment followed by right lower lobectomy using uniportal video-assisted thoracoscopic surgery after attaining a pathological diagnosis of adenocarcinoma. The patient developed no acute exacerbations of IPF during the postoperative period, and she had no recurrence of lung cancer for 15 months after surgery. We successfully used a combination of perioperative antifibrotic medication and minimally invasive surgery after lung cancer surgery in a patient with IPF.

Sign in / Sign up

Export Citation Format

Share Document